BANGKOK (NNT) – Thailand’s government has launched a pilot “Factory Sandbox” program to test, vaccinate and isolate factory workers, with the aim of limiting COVID-related disruptions to Thailand’s important export-driven manufacturing sector.

According to a government statement, this initiative aims to protect 3 million jobs and supports manufacturers who contribute about 700 billion baht to the gross domestic product. The plan will focus on plants which employ at least 500 people and will build confidence among both Thai and foreign investors at a time when supply chains in rival countries are shutting down.

The “sandbox” program will focus on large factories manufacturing cars, electronics, food and medical equipment for export, in provinces which are key production hubs. Eligible factories must employ at least 500 workers, a field hospital or isolation facility and shuttle services for employees.

All workers will also be tested for the coronavirus and those who test positive will be isolated, while cohorts will be inoculated, with subsequent tests done every seven days. Sixty factories in Nonthaburi, Pathum Thani, Samut Sakhon and Chonburi, with a combined workforce of 138,000, will participate in the initial phase.

Information and Source
Reporter : Subhabhong Rarueysong
Rewriter : Hugh Brammar
National News Bureau & Public Relations : http://thainews.prd.go.th

About the author

Leave a Reply

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

French oil company TotalEnergies withdraws from Myanmar

TotalEnergies has not been able to meet the expectations of many stakeholders (shareholders, international and Burmese civil society organisations), who are calling to stop the revenues going to the Burmese state through the state-owned company MOGE from the Yadana field production.

Thailand BOI Approves Measures to Support Carbon Reduction

greenhouse gas emission as well as an enhanced scheme for electric vehicles and measures to mitigate Covid-19 impacts and support local vaccine development